But a spokesperson for the company told CNBC that all intellectual property decisions are "carefully considered," adding that "periods of exclusivity for pharmaceutical products end as part of their normal life cycle and generic treatments may become available over time." This announcement by Hims follows the closing of the company's recent acquisition ofEuropean telehealth platform Zava, which expands the health platform in Europe to Ireland, France and Germany
By learning more about these molecular details, we hope to ultimately unlock explanations for neurodegeneration, which would give us opportunities for finding ways to protect the brain. This research was supported in part by the National Institute of Neurological Disorders and Stroke and the National Cancer Institute, both part of the National Institutes of Health, through grant numbers NS036942, NS11739 and F31CA278383
It involves communication between peripheral tissues, such as adipose tissue, and central nervous system structures, including the hypothalamus and higher cortical centers
What should I do if my provider doesnt recognize Surest
Were committed to managing your expectations for both immediate and sustainable results